The 12 analysts offering 12-month price forecasts for Eli Lilly and Co have a median target of 141.00, with a high estimate of 156.00 and a low estimate of 93.00. The median estimate represents a +0.06% increase from the last price of 140.91.
The current consensus among 15 polled investment analysts is to Buy stock in Eli Lilly and Co. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.52
Reporting Date Jan 30
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.